Clinical Trials Directory

Trials / Unknown

UnknownNCT01537263

Ultrasound Perfusion Imaging After Aneurysmal Subarachnoid Hemorrhage

Status
Unknown
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Asklepios Kliniken Hamburg GmbH · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to examine wether delayed cerebral ischemia can be predicted by ultrasound brain perfusion imaging in patients with aneurysmal subarachnoid hemorrhage (SAH).

Detailed description

The delayed cerebral ischemia is a main complication in patient with aneurysmal subarachnoid hemorrhage which causes neurological deficit. So far there is no reliable diagnostic tool to predict the appearance of cerebral ischemia. The causal correlation between presence of cerebral vasospasm measured daily by transcranial Doppler sonography (TCD) and occurrence of cerebral ischemia detected by cranial computed tomography scan (CCT) is not finally verified. First studies demonstrated that ultrasound perfusion imaging (UPI) allows the detection of perfusion deficits in middle cerebral artery infarction. The purpose of our study is to evaluate the diagnostic and prognostic value of UPI to predict delayed cerebral ischemia. In our trial we compare parameters of UPI (b= rise rate, A= plateau of acoustic intensity) in patients with aneurysmal subarachnoid hemorrhage with results of follow-up cranial computed tomography scans (CCT), TCD results and clinical outcome.

Conditions

Interventions

TypeNameDescription
DEVICEUltrasound Perfusion ImagingSonographic unit Phillips IU 22, 5ml SonoVue ultrasound contrast agent per examination, Duration: 1h

Timeline

Start date
2012-01-01
Primary completion
2014-01-01
Completion
2014-01-01
First posted
2012-02-23
Last updated
2012-04-06

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01537263. Inclusion in this directory is not an endorsement.